Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study.

Avner EhrlichKonstantinos IoannidisMakram NasarIsmaeel Abu AlkianYuval DaskalNofar AtariLimor KlikerNir RainyMatan HofreeSigal Shafran TikvaInbal HouriArrigo CiceroChiara PavanelloCesare R SirtoriJordana B CohenJulio A ChirinosLisa DeutschMerav CohenAmichai GottliebAdina Bar-ChaimOren ShiboletMichal MandelboimShlomo MaayanYaakov Nahmias

Published in: eLife (2023)

Clinical trial number: NCT04661930.

Keyphrases

open label
clinical trial
phase ii
phase iii
double blind
coronavirus disease
phase ii study
study protocol
sars cov
physical activity
placebo controlled
squamous cell carcinoma
drug induced
cross sectional
radiation therapy